BeOne Medicines
ONC
#769
Rank
C$44.48 B
Marketcap
C$428.77
Share price
0.20%
Change (1 day)
30.73%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): C$6.65

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is C$6.65. In 2025 the company made an earnings per share (EPS) of C$3.77 an increase over its 2024 EPS that were of C-$8.62.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$6.6576.23%
2025C$3.77-143.75%
2024C-$8.62
2022C-$26.9528.21%
2021C-$21.02-19.96%
2020C-$26.2620.81%
2019C-$21.7431.52%
2018C-$16.53417.57%
2017C-$3.19-37.16%
2016C-$5.08158.95%
2015C-$1.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.33-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.31-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA